We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-13.16%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.2B
AUM Growth
-$730M
Cap. Flow
-$164M
Cap. Flow %
-5.14%
Top 10 Hldgs %
14.44%
Holding
1,433
New
85
Increased
447
Reduced
621
Closed
196

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$7.65M
2
VZ icon
Verizon
VZ
+$4.92M
3
LIN icon
Linde
LIN
+$4.78M
4
ILMN icon
Illumina
ILMN
+$4.5M
5
AAPL icon
Apple
AAPL
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 13.46%
2 Technology 12.76%
3 Financials 11.37%
4 Industrials 8.31%
5 Consumer Discretionary 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
26
Merck
MRK
$318B
$22.4M 0.7%
306,955
-823
-0.3% -$58.1K
GOOGL icon
27
Alphabet (Google) Class A
GOOGL
$4.33T
$22.4M 0.7%
428,240
-760
-0.2% -$41.1K
BAC icon
28
Bank of America
BAC
$442B
$21.7M 0.68%
880,063
-155,331
-15% -$4.21M
DD icon
29
DuPont de Nemours
DD
$19.2B
$21.4M 0.67%
158,305
-3,424
-2% -$492K
EPD icon
30
Enterprise Products Partners
EPD
$81.7B
$21.2M 0.66%
861,779
+22,389
+3% +$599K
INTC icon
31
Intel
INTC
$513B
$19.6M 0.61%
417,541
+11,117
+3% +$521K
TMO icon
32
Thermo Fisher Scientific
TMO
$220B
$19.5M 0.61%
87,325
-4,901
-5% -$1.15M
COST icon
33
Costco
COST
$420B
$19.5M 0.61%
95,667
-20,480
-18% -$4.57M
CVX icon
34
Chevron
CVX
$366B
$18.6M 0.58%
171,277
+11,792
+7% +$1.37M
MTUM icon
35
iShares MSCI USA Momentum Factor ETF
MTUM
$26.2B
$18.5M 0.58%
184,585
-28,203
-13% -$3.02M
PEP icon
36
PepsiCo
PEP
$190B
$17.6M 0.55%
159,520
-996
-0.6% -$112K
ABBV icon
37
AbbVie
ABBV
$435B
$17.5M 0.55%
190,081
-3,781
-2% -$333K
LUV icon
38
Southwest Airlines
LUV
$23B
$17.3M 0.54%
372,201
-1,356
-0.4% -$72K
PG icon
39
Procter & Gamble
PG
$339B
$16.2M 0.51%
176,396
-4,887
-3% -$437K
MDT icon
40
Medtronic
MDT
$112B
$16.2M 0.51%
178,186
+27,744
+18% +$2.59M
UNH icon
41
UnitedHealth
UNH
$370B
$16.1M 0.5%
64,809
-2,032
-3% -$537K
HON icon
42
Honeywell
HON
$78B
$15.9M 0.5%
127,968
-4,558
-3% -$622K
BMY icon
43
Bristol-Myers Squibb
BMY
$132B
$15.9M 0.5%
306,203
-35,746
-10% -$1.92M
C icon
44
Citigroup
C
$226B
$15.9M 0.5%
305,305
-49,676
-14% -$3.15M
AFL icon
45
Aflac
AFL
$62.6B
$15.4M 0.48%
338,139
-2,953
-0.9% -$131K
NVGS icon
46
Navigator Holdings
NVGS
$1.28B
$15.2M 0.47%
1,613,758
-26,035
-2% -$300K
EFA icon
47
iShares MSCI EAFE ETF
EFA
$80.2B
$14.9M 0.46%
252,873
+30,942
+14% +$1.93M
EHC icon
48
Encompass Health
EHC
$12.4B
$14.3M 0.45%
290,561
+3,771
+1% +$214K
MDY icon
49
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$14.3M 0.45%
47,097
-641
-1% -$213K
IBM icon
50
IBM
IBM
$224B
$14.1M 0.44%
129,676
-40,836
-24% -$4.9M

Similar funds

Oppenheimer & Co's Q4 2018 Portfolio in Review

As of Q4 2018, Oppenheimer & Co held 1,433 positions worth $3.2B, down 19% from $3.93B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $164M in Q4 2018, closing 196 positions and reducing 621 holdings. Its most notable exit was Etsy, an estimated $6.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, Oppenheimer & Co opened a new position in Linde worth $4.72M.

  • Oppenheimer & Co's largest Q4 2018 buy was Linde: 30,256 shares worth $4.72M.
  • Oppenheimer & Co added most to iShares 20+ Year Treasury Bond ETF in Q4 2018, an estimated $7.65M increase.
  • Oppenheimer & Co's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $9.23M.
  • Oppenheimer & Co fully exited Etsy in Q4 2018, selling an estimated $6.87M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.2B portfolio in Q4 2018.
  • Oppenheimer & Co opened 85 new positions and closed 196 in Q4 2018.
  • Oppenheimer & Co's portfolio value fell 19% quarter-over-quarter to $3.2B.

Based on Oppenheimer & Co's 13F filing for Q4 2018, filed 29 Jan 2019.